Life Sciences, RNA Editing
Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...
Wave Life Sciences' WVE-006 study shows significant promise in treating alpha-1 antitrypsin deficiency. Learn more about WVE ...
CHICOPEE — Agilent Technologies in Chicopee received a $250,000 life sciences tax incentive and has committed to adding 10 ...
GTCR has announced it will acquire TRANZACT. TRANZACT, founded in 1997 and based in Fort Lee, New Jersey, is a ...
Private equity investors including Quadria Capital and TPG Capital have expressed initial interest to invest about $100 ...
Two western Massachusetts life science companies are among 19 across the state to receive tax incentive awards.
The Texas Research Quarter is betting big on making Plano and North Texas a hub for life sciences. The development by ...
The $700 million Taystee Lab Building sits in the Manhattanville Factory District, but the laboratory goes beyond West Harlem ...
Stagnant for more than a year, Philadelphia’s life sciences leasing market is starting to percolate and industry insiders are ...
This report series examines quarterly trends in life sciences venture investment. Key findings for Q2 2024 include: • Life sciences VC deal ...
Kezar Life Sciences announced the termination of Phase 2b PALIZADE clinical trial of zetomipzomib, an investigational therapy ...